Aedifica NV/SA

LSE:0DKX Stock Report

Market Cap: €2.7b

Aedifica/SA Past Earnings Performance

Past criteria checks 3/6

Aedifica/SA's earnings have been declining at an average annual rate of -2.8%, while the Health Care REITs industry saw earnings growing at 5% annually. Revenues have been growing at an average rate of 17.7% per year. Aedifica/SA's return on equity is 2.9%, and it has net margins of 31.1%.

Key information

-2.8%

Earnings growth rate

-13.8%

EPS growth rate

Health Care REITs Industry Growth7.7%
Revenue growth rate17.7%
Return on equity2.9%
Net Margin31.1%
Next Earnings Update19 Feb 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Aedifica/SA makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

LSE:0DKX Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24341106340
30 Jun 24334110340
31 Mar 2432784350
31 Dec 2332125340
30 Sep 2331243320
30 Jun 23301150310
31 Mar 23290231310
31 Dec 22279332320
30 Sep 22273489320
30 Jun 22265408310
31 Mar 22254354320
31 Dec 21243282280
30 Sep 21216221270
30 Jun 21198193250
31 Mar 21188150250
31 Dec 20179115240
30 Jun 20169105230
31 Mar 20157129200
31 Dec 19146154170
30 Sep 19134139150
30 Jun 19122123150
31 Mar 1911199130
31 Dec 1810074110
30 Sep 189773110
30 Jun 189472100
31 Mar 189272100
31 Dec 17897390
30 Sep 17856890
30 Jun 17826380
31 Mar 17765480
31 Dec 16714470
30 Sep 16664270
30 Jun 16624060
31 Mar 16604460
31 Dec 15584760
30 Sep 15554650
30 Jun 15524550
31 Mar 15493850
31 Dec 14453140
30 Sep 14442640
30 Jun 14422140
31 Mar 14402240
31 Dec 13392340

Quality Earnings: 0DKX has a large one-off loss of €136.3M impacting its last 12 months of financial results to 30th September, 2024.

Growing Profit Margin: 0DKX's current net profit margins (31.1%) are higher than last year (13.9%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 0DKX's earnings have declined by 2.8% per year over the past 5 years.

Accelerating Growth: 0DKX's earnings growth over the past year (144.4%) exceeds its 5-year average (-2.8% per year).

Earnings vs Industry: 0DKX earnings growth over the past year (144.4%) exceeded the Health Care REITs industry 29.2%.

Return on Equity

High ROE: 0DKX's Return on Equity (2.9%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 18:51
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Aedifica NV/SA is covered by 22 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Veronique MeertensABN AMRO Bank N.V.
Eric WilmerABN AMRO Bank N.V.
Celine Soo-HuynhBarclays